HWKN
HWKN
Hawkins, Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2026 | $265.91M ▲ | $32.18M ▲ | $15.46M ▲ | 5.82% ▼ | $0.75 ▲ | $35.63M ▲ |
| Q3-2026 | $244.08M ▼ | $31.98M ▼ | $14.31M ▼ | 5.86% ▼ | $0.69 ▼ | $32.25M ▼ |
| Q2-2026 | $280.43M ▼ | $33.17M ▲ | $22.6M ▼ | 8.06% ▼ | $1.09 ▼ | $47.74M ▼ |
| Q1-2026 | $293.27M ▲ | $32.61M ▲ | $29.18M ▲ | 9.95% ▲ | $1.41 ▲ | $52.04M ▲ |
| Q4-2025 | $245.32M | $23.77M | $16.33M | 6.66% | $0.79 | $35.5M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2026 | $3.91M ▼ | $1B ▲ | $467.69M ▲ | $534.01M ▲ |
| Q3-2026 | $8.21M ▼ | $976.53M ▼ | $457.62M ▼ | $518.91M ▲ |
| Q2-2026 | $10.41M ▼ | $984.16M ▼ | $477.2M ▼ | $506.97M ▲ |
| Q1-2026 | $14.5M ▲ | $988.27M ▲ | $503.7M ▲ | $484.57M ▲ |
| Q4-2025 | $5.1M | $769.87M | $309.57M | $460.29M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2026 | $15.46M ▲ | $37.73M ▲ | $-19.49M ▼ | $-22.54M ▼ | $-4.29M ▼ | $18.16M ▼ |
| Q3-2026 | $14.31M ▼ | $35.56M ▼ | $-18.8M ▲ | $-18.97M ▲ | $-2.21M ▲ | $21.24M ▼ |
| Q2-2026 | $22.6M ▼ | $39.54M ▲ | $-21.27M ▲ | $-22.36M ▼ | $-4.09M ▼ | $28.74M ▲ |
| Q1-2026 | $29.18M ▲ | $31.49M ▲ | $-164.54M ▼ | $142.45M ▲ | $9.4M ▲ | $17.95M ▼ |
| Q4-2025 | $16.33M | $30.84M | $-55.13M | $21.08M | $-3.2M | $19.76M |
Revenue by Products
| Product | Q1-2026 | Q2-2026 | Q3-2026 | Q4-2026 |
|---|---|---|---|---|
Agricultural | $20.00M ▲ | $10.00M ▼ | $10.00M ▲ | $20.00M ▲ |
Bulk products | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ | $0 ▼ |
Food | $30.00M ▲ | $20.00M ▼ | $30.00M ▲ | $20.00M ▼ |
Nutrition | $40.00M ▲ | $30.00M ▼ | $20.00M ▼ | $40.00M ▲ |
Other | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Pharmaceutical | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ |
5-Year Trend Analysis
A comprehensive look at Hawkins, Inc.'s financial evolution and strategic trajectory over the past five years.
Hawkins combines solid profitability, strong cash generation, and a conservative capital structure with a differentiated operating model in niche but essential markets. Its diversified segments—water treatment, health and nutrition, and industrial chemicals—provide multiple revenue streams and reduce reliance on any single end market. Operationally, the company excels in logistics, custom blending, and service, which, together with advanced water technologies and specialty ingredients, create meaningful switching costs for customers. Liquidity is sound, leverage is moderate and manageable, and retained earnings are substantial, reflecting years of consistent profitability. Overall, the business profile is that of a disciplined, service‑oriented operator with real staying power.
Key risks center on the quality and composition of the balance sheet, the sustainability of growth, and the complexity of its operating environment. A large share of assets is tied to goodwill and other intangibles from acquisitions, which could be vulnerable to impairment if acquired businesses underperform. The modest cash balance relative to debt and ongoing investment needs increases reliance on continued strong cash generation and credit market access. Limited visibility into explicit R&D spending raises concerns about whether innovation is adequately funded internally or overly dependent on acquisitions. External risks include regulatory changes in chemicals and water treatment, environmental liabilities, cyclical end‑market demand, integration risks from continued deal‑making, and competition from both large global distributors and nimble local players.
From the available information, Hawkins appears positioned for steady, rather than explosive, progress, underpinned by strong margins, recurring cash flows, and essential end markets like water and food-related nutrition. Opportunities in advanced water treatment—especially around emerging contaminants—and in higher‑value, clean‑label nutrition ingredients could support mix improvement and gradual growth. Continued disciplined acquisitions and capital investments may further expand capabilities and geographic reach, provided they are integrated well and deliver the expected returns. At the same time, the company’s future success will hinge on maintaining balance sheet strength, funding and executing on innovation, and navigating regulatory and competitive pressures. Overall, the outlook suggests a stable, cash‑generative business with room for incremental value creation but also a need for careful capital allocation and ongoing strategic execution.
About Hawkins, Inc.
https://www.hawkinsinc.comHawkins, Inc. blends, manufactures, and distributes chemicals and other specialty ingredients in the United States and internationally. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2026 | $265.91M ▲ | $32.18M ▲ | $15.46M ▲ | 5.82% ▼ | $0.75 ▲ | $35.63M ▲ |
| Q3-2026 | $244.08M ▼ | $31.98M ▼ | $14.31M ▼ | 5.86% ▼ | $0.69 ▼ | $32.25M ▼ |
| Q2-2026 | $280.43M ▼ | $33.17M ▲ | $22.6M ▼ | 8.06% ▼ | $1.09 ▼ | $47.74M ▼ |
| Q1-2026 | $293.27M ▲ | $32.61M ▲ | $29.18M ▲ | 9.95% ▲ | $1.41 ▲ | $52.04M ▲ |
| Q4-2025 | $245.32M | $23.77M | $16.33M | 6.66% | $0.79 | $35.5M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2026 | $3.91M ▼ | $1B ▲ | $467.69M ▲ | $534.01M ▲ |
| Q3-2026 | $8.21M ▼ | $976.53M ▼ | $457.62M ▼ | $518.91M ▲ |
| Q2-2026 | $10.41M ▼ | $984.16M ▼ | $477.2M ▼ | $506.97M ▲ |
| Q1-2026 | $14.5M ▲ | $988.27M ▲ | $503.7M ▲ | $484.57M ▲ |
| Q4-2025 | $5.1M | $769.87M | $309.57M | $460.29M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2026 | $15.46M ▲ | $37.73M ▲ | $-19.49M ▼ | $-22.54M ▼ | $-4.29M ▼ | $18.16M ▼ |
| Q3-2026 | $14.31M ▼ | $35.56M ▼ | $-18.8M ▲ | $-18.97M ▲ | $-2.21M ▲ | $21.24M ▼ |
| Q2-2026 | $22.6M ▼ | $39.54M ▲ | $-21.27M ▲ | $-22.36M ▼ | $-4.09M ▼ | $28.74M ▲ |
| Q1-2026 | $29.18M ▲ | $31.49M ▲ | $-164.54M ▼ | $142.45M ▲ | $9.4M ▲ | $17.95M ▼ |
| Q4-2025 | $16.33M | $30.84M | $-55.13M | $21.08M | $-3.2M | $19.76M |
Revenue by Products
| Product | Q1-2026 | Q2-2026 | Q3-2026 | Q4-2026 |
|---|---|---|---|---|
Agricultural | $20.00M ▲ | $10.00M ▼ | $10.00M ▲ | $20.00M ▲ |
Bulk products | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ | $0 ▼ |
Food | $30.00M ▲ | $20.00M ▼ | $30.00M ▲ | $20.00M ▼ |
Nutrition | $40.00M ▲ | $30.00M ▼ | $20.00M ▼ | $40.00M ▲ |
Other | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Pharmaceutical | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ |
5-Year Trend Analysis
A comprehensive look at Hawkins, Inc.'s financial evolution and strategic trajectory over the past five years.
Hawkins combines solid profitability, strong cash generation, and a conservative capital structure with a differentiated operating model in niche but essential markets. Its diversified segments—water treatment, health and nutrition, and industrial chemicals—provide multiple revenue streams and reduce reliance on any single end market. Operationally, the company excels in logistics, custom blending, and service, which, together with advanced water technologies and specialty ingredients, create meaningful switching costs for customers. Liquidity is sound, leverage is moderate and manageable, and retained earnings are substantial, reflecting years of consistent profitability. Overall, the business profile is that of a disciplined, service‑oriented operator with real staying power.
Key risks center on the quality and composition of the balance sheet, the sustainability of growth, and the complexity of its operating environment. A large share of assets is tied to goodwill and other intangibles from acquisitions, which could be vulnerable to impairment if acquired businesses underperform. The modest cash balance relative to debt and ongoing investment needs increases reliance on continued strong cash generation and credit market access. Limited visibility into explicit R&D spending raises concerns about whether innovation is adequately funded internally or overly dependent on acquisitions. External risks include regulatory changes in chemicals and water treatment, environmental liabilities, cyclical end‑market demand, integration risks from continued deal‑making, and competition from both large global distributors and nimble local players.
From the available information, Hawkins appears positioned for steady, rather than explosive, progress, underpinned by strong margins, recurring cash flows, and essential end markets like water and food-related nutrition. Opportunities in advanced water treatment—especially around emerging contaminants—and in higher‑value, clean‑label nutrition ingredients could support mix improvement and gradual growth. Continued disciplined acquisitions and capital investments may further expand capabilities and geographic reach, provided they are integrated well and deliver the expected returns. At the same time, the company’s future success will hinge on maintaining balance sheet strength, funding and executing on innovation, and navigating regulatory and competitive pressures. Overall, the outlook suggests a stable, cash‑generative business with room for incremental value creation but also a need for careful capital allocation and ongoing strategic execution.

CEO
Patrick H. Hawkins
Compensation Summary
(Year 2025)
Upcoming Earnings
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2021-03-02 | Forward | 2:1 |
| 1997-03-25 | Forward | 21:20 |
ETFs Holding This Stock
Summary
Showing Top 3 of 202
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
BLACKROCK, INC.
Shares:3.21M
Value:$497.18M
BLACKROCK INC.
Shares:3.16M
Value:$489.25M
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC
Shares:1.53M
Value:$236.19M
Summary
Showing Top 3 of 423

